Molecular modeling of the second extracellular loop of G‐protein coupled receptors and its implication on structure‐based virtual screening
暂无分享,去创建一个
Ola Engkvist | Didier Rognan | Chris de Graaf | Nicolas Foata | D. Rognan | O. Engkvist | C. de Graaf | Nicolas Foata
[1] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[2] C. Davies,et al. Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties. , 2006, European journal of pharmacology.
[3] H. Wikström,et al. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT. , 1999, Bioorganic & medicinal chemistry.
[4] L. Naylor,et al. Structural Studies on D2 Dopamine Receptors: Mutation of a Histidine Residue Specifically Affects the Binding of a Subgroup of Substituted Benzamide Drugs , 1994, Journal of neurochemistry.
[5] Bernard Pirotte,et al. From the design to the clinical application of thromboxane modulators. , 2006, Current pharmaceutical design.
[6] D. Rognan,et al. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.
[7] J. Turek,et al. Differential Mapping of the Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein* , 2006, Journal of Biological Chemistry.
[8] P. Pauwels,et al. Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding. , 1998, Molecular pharmacology.
[9] Andreas Evers,et al. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols. , 2005, Journal of medicinal chemistry.
[10] Sergio A Hassan,et al. Ab initio computational modeling of loops in G‐protein‐coupled receptors: Lessons from the crystal structure of rhodopsin , 2006, Proteins.
[11] J. Pin,et al. Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. , 2005, Journal of medicinal chemistry.
[12] T. Klabunde,et al. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor. , 2005, Journal of medicinal chemistry.
[13] G. Bokoch,et al. Binding of Low Affinity N-formyl Peptide Receptors to G Protein , 1995, The Journal of Biological Chemistry.
[14] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[15] K. Jacobson,et al. Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.
[16] Kenneth A Jacobson,et al. Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor. , 2006, Journal of molecular graphics & modelling.
[17] Thomas Lengauer,et al. Lead Identification by Virtual Screening , 2007 .
[18] Cathy H. Wu,et al. The Universal Protein Resource (UniProt): an expanding universe of protein information , 2005, Nucleic Acids Res..
[19] L. Audoly,et al. The Second Extracellular Loop of the Prostaglandin EP3 Receptor Is an Essential Determinant of Ligand Selectivity* , 1997, The Journal of Biological Chemistry.
[20] J. Bockaert,et al. Molecular Characterization of a Purified 5-HT4 Receptor , 2005, Journal of Biological Chemistry.
[21] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[22] Giampiero Spalluto,et al. Progress in the pursuit of therapeutic adenosine receptor antagonists , 2006, Medicinal research reviews.
[23] Didier Rognan,et al. Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets? , 2002, Proteins.
[24] Pieter F. W. Stouten,et al. Fast prediction and visualization of protein binding pockets with PASS , 2000, J. Comput. Aided Mol. Des..
[25] E A Merritt,et al. Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.
[26] Krzysztof Palczewski,et al. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. , 2003, Biochemistry.
[27] Didier Rognan,et al. High-Throughput Modeling of Human G-Protein Coupled Receptors: Amino Acid Sequence Alignment, Three-Dimensional Model Building, and Receptor Library Screening , 2004, J. Chem. Inf. Model..
[28] Didier Rognan,et al. A chemogenomic analysis of the transmembrane binding cavity of human G‐protein‐coupled receptors , 2005, Proteins.
[29] K. Marx,et al. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction. , 1997, Biochemistry.
[30] K. Jacobson,et al. Identification by Site-directed Mutagenesis of Residues Involved in Ligand Recognition and Activation of the Human A3 Adenosine Receptor* , 2002, The Journal of Biological Chemistry.
[31] E. Meng,et al. Rhodopsin Sees the Light , 2000, Science.
[32] Thomas Lengauer,et al. Evaluation of the FLEXX incremental construction algorithm for protein–ligand docking , 1999, Proteins.
[33] L. Naylor,et al. Effect of Multiple Serine/Alanine Mutations in the Transmembrane Spanning Region V of the D2 Dopamine Receptor on Ligand Binding , 2000, Journal of neurochemistry.
[34] J. Hwa,et al. Clusters of transmembrane residues are critical for human prostacyclin receptor activation. , 2004, Biochemistry.
[35] D. Rognan,et al. Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors. , 2007, Molecular endocrinology.
[36] Lei Shi,et al. The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[37] John Hwa,et al. The Unique Ligand-binding Pocket for the Human Prostacyclin Receptor , 2003, The Journal of Biological Chemistry.
[38] Peter L. Freddolino,et al. Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] Yang Zhang,et al. Structure Modeling of All Identified G Protein–Coupled Receptors in the Human Genome , 2006, PLoS Comput. Biol..
[40] J. Ballesteros,et al. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. , 1998, Biochemistry.
[41] T. Sakmar,et al. Rhodopsin: structural basis of molecular physiology. , 2001, Physiological reviews.
[42] K. Jacobson,et al. Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors. , 1994, The Journal of biological chemistry.
[43] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[44] R. Hermosilla,et al. The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues , 2000, FEBS letters.
[45] Shay Bar-Haim,et al. G protein-coupled receptors: in silico drug discovery in 3D. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Teulon,et al. Synthesis and structure-activity relationships of novel benzimidazole and imidazo[4,5-b]pyridine acid derivatives as thromboxane A2 receptor antagonists. , 1993, Journal of medicinal chemistry.
[47] D. Higgins,et al. T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.
[48] H. Perez,et al. Human formyl peptide receptor ligand binding domain(s). Studies using an improved mutagenesis/expression vector reveal a novel mechanism for the regulation of receptor occupancy. , 1994, The Journal of biological chemistry.
[49] J. Ballesteros,et al. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. , 1999, Molecular pharmacology.
[50] J. Wess,et al. Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition. , 1996, Molecular pharmacology.
[51] G. FitzGerald,et al. Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. , 1993, Molecular pharmacology.
[52] E. Green,et al. Novel human α1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function , 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.
[53] Gert Vriend,et al. GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..
[54] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[55] J. Hwa,et al. Human prostacyclin receptor structure and function from naturally-occurring and synthetic mutations. , 2007, Prostaglandins & other lipid mediators.
[56] E. Jaeger,et al. Comparison of automated docking programs as virtual screening tools. , 2005, Journal of Medicinal Chemistry.
[57] Structure. Rhodopsin sees the light. , 2000, Science.
[58] Malin M. Young,et al. Structure and dynamics of dark‐state bovine rhodopsin revealed by chemical cross‐linking and high‐resolution mass spectrometry , 2006, Protein science : a publication of the Protein Society.
[59] Robert P Bywater,et al. Location and nature of the residues important for ligand recognition in G‐protein coupled receptors , 2005, Journal of molecular recognition : JMR.
[60] K. Jacobson,et al. Nucleoside Modification and Concerted Mutagenesis of the Human A3 Adenosine Receptor to Probe Interactions Between the 2-Position of Adenosine Analogs and Gln167 in the Second Extracellular Loop , 2005, Nucleosides, nucleotides & nucleic acids.
[61] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[62] K Ezumi,et al. Computer-aided molecular modeling of a thromboxane receptor antagonist S-145 and its related compounds. , 1990, Journal of medicinal chemistry.
[63] Michael G. Davis,et al. Mutagenic Analysis of Platelet Thromboxane Receptor Cysteines , 1996, The Journal of Biological Chemistry.
[64] D. Perez,et al. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding. , 1996, Molecular pharmacology.
[65] Stephen Hanessian,et al. A method for induced-fit docking, scoring, and ranking of flexible ligands. Application to peptidic and pseudopeptidic beta-secretase (BACE 1) inhibitors. , 2006, Journal of medicinal chemistry.
[66] Richard D. Taylor,et al. Improved protein–ligand docking using GOLD , 2003, Proteins.
[67] D. Scholl,et al. Serine and alanine mutagenesis of the nine native cysteine residues of the human A(1) adenosine receptor. , 2000, Biochemical pharmacology.
[68] Kenneth A. Jacobson,et al. The Role of Amino Acids in Extracellular Loops of the Human P2Y1 Receptor in Surface Expression and Activation Processes* , 1999, The Journal of Biological Chemistry.
[69] P. Seeman. Targeting the dopamine D2 receptor in schizophrenia , 2006, Expert opinion on therapeutic targets.
[70] L. Audoly,et al. A conserved threonine in the second extracellular loop of the human EP2 and EP4 receptors is required for ligand binding. , 1998, European journal of pharmacology.
[71] K. Ruan,et al. A strategy using NMR peptide structures of thromboxane A2 receptor as templates to construct ligand-recognition pocket of prostacyclin receptor , 2005, BMC Biochemistry.
[72] Luis Moroder,et al. Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor. , 2005, Journal of medicinal chemistry.
[73] Kurt Kristiansen,et al. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. , 2004, Pharmacology & therapeutics.
[74] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[75] R. Graham,et al. The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines. , 1994, The Journal of biological chemistry.
[76] Adam J Pawson,et al. Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment. , 1997, Biochemistry.
[77] K. Jacobson,et al. Constitutive activation of A(3) adenosine receptors by site-directed mutagenesis. , 2001, Biochemical and biophysical research communications.
[78] Marc Parmentier,et al. The Core Domain of Chemokines Binds CCR5 Extracellular Domains while Their Amino Terminus Interacts with the Transmembrane Helix Bundle* , 2003, The Journal of Biological Chemistry.
[79] R. Jensen,et al. Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide. , 2002, Molecular pharmacology.
[80] Leonardo Pardo,et al. An Activation Switch in the Rhodopsin Family of G Protein-coupled Receptors , 2005, Journal of Biological Chemistry.
[81] H. Levine,et al. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints. , 2004, Biochemistry.
[82] K. Jacobson,et al. Constitutive Activation of A3 Adenosine Receptors by Site-Directed Mutagenesis , 2001 .
[83] J. Klco,et al. Essential role for the second extracellular loop in C5a receptor activation , 2005, Nature Structural &Molecular Biology.
[84] Gilles Marcou,et al. Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints , 2007, J. Chem. Inf. Model..
[85] Lei Shi,et al. The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. , 2002, Annual review of pharmacology and toxicology.
[86] Maya Topf,et al. PREDICT modeling and in‐silico screening for G‐protein coupled receptors , 2004, Proteins.
[87] Robert H Mach,et al. Synthesis and characterization of selective dopamine D2 receptor antagonists. , 2006, Bioorganic & medicinal chemistry.
[88] Manfred Burghammer,et al. Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.
[89] J. Fozard,et al. A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential. , 2005, Bioorganic & medicinal chemistry letters.
[90] O. Kocy,et al. Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists. , 1993, Journal of medicinal chemistry.
[91] P. Pauwels,et al. Coupling of Canine Serotonin 5‐HT1B and 5‐HT1D Receptor Subtypes to the Formation of Inositol Phosphates by Dual Interactions with Endogenous Gi/o and Recombinant Gα15 Proteins , 2000, Journal of neurochemistry.
[92] Gerhard Hessler,et al. Drug Design Strategies for Targeting G‐Protein‐Coupled Receptors , 2002, Chembiochem : a European journal of chemical biology.
[93] M. P. Turpin,et al. Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus system. , 1998, Journal of receptor and signal transduction research.
[94] K. Jacobson,et al. Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. , 2001, Journal of medicinal chemistry.
[95] Didier Rognan,et al. Comparative evaluation of eight docking tools for docking and virtual screening accuracy , 2004, Proteins.